Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD

American Journal of Kidney Diseases

Volumn 61, Issue 1, 2013, Pages 67-73

  Smith, Kelsey ^a   Defilippi, Christopher ^b   Isakova, Tamara ^a   Gutiérrez, Orlando M ^c   Laliberte, Karen ^d   Seliger, Stephen ^b   Kelley, Walter ^b   Duh, Show Hong ^b   Hise, Michael ^b   Christenson, Robert ^b   Wolf, Myles ^a   Januzzi, James ^d  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

chronic kidney disease; Fibroblast growth factor 23; high sensitivity cardiac troponin; left ventricular hypertrophy

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; HIGH SENSITIVITY CARDIAC TROPONIN I; HIGH SENSITIVITY CARDIAC TROPONIN T; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CROSS-SECTIONAL STUDY; DIALYSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; OUTPATIENT; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SELF REPORT; VITAMIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 84871236512     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.06.022     Document Type: Article

References (49)

1. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
2. US Renal Data System USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States Am J Kidney Dis 59 1 suppl 1 2012 e1 e420
3. R.J. Middleton, P.S. Parfrey, R.N. Foley Left ventricular hypertrophy in the renal patient J Am Soc Nephrol 12 5 2001 1079 1084 (Pubitemid 32378350)
4. O.M. Gutierrez, M. Mannstadt, T. Isakova Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 6 2008 584 592
5. T. Isakova, H. Xie, W. Yang Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease JAMA 305 23 2011 2432 2439
6. J. Kendrick, A.K. Cheung, J.S. Kaufman FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis J Am Soc Nephrol 22 10 2011 1913 1922
7. O. Gutierrez, T. Isakova, E. Rhee Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease J Am Soc Nephrol 16 7 2005 2205 2215 (Pubitemid 41716454)
8. T. Larsson, U. Nisbeth, O. Ljunggren, H. Juppner, K.B. Jonsson Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers Kidney Int 64 6 2003 2272 2279 (Pubitemid 37449564)
9. T. Shigematsu, J.J. Kazama, T. Yamashita Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency Am J Kidney Dis 44 2 2004 250 256 (Pubitemid 38962552)
10. O.M. Gutierrez, J.L. Januzzi, T. Isakova Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease Circulation 119 19 2009 2545 2552
11. M.A. Mirza, A. Larsson, H. Melhus, L. Lind, T.E. Larsson Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population Atherosclerosis 207 2 2009 546 551
12. B.D. Parker, L.J. Schurgers, V.M. Brandenburg The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study Ann Intern Med 152 10 2010 640 648
13. C. Faul, A.P. Amaral, B. Oskouei FGF23 induces left ventricular hypertrophy J Clin Invest 121 11 2011 4393 4408
14. B.J. Freda, W.H. Tang, F. Van Lente, W.F. Peacock, G.S. Francis Cardiac troponins in renal insufficiency: review and clinical implications J Am Coll Cardiol 40 12 2002 2065 2071 (Pubitemid 36005889)
15. K. Thygesen, J.S. Alpert, H.D. White Universal definition of myocardial infarction Circulation 116 22 2007 2634 2653 (Pubitemid 350182388)
16. T.W. Wallace, S.M. Abdullah, M.H. Drazner Prevalence and determinants of troponin T elevation in the general population Circulation 113 16 2006 1958 1965
17. C. Roongsritong, I. Warraich, C. Bradley Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance Chest 125 5 2004 1877 1884 (Pubitemid 38648423)
18. T. Omland, J.A. de Lemos, M.S. Sabatine A sensitive cardiac troponin T assay in stable coronary artery disease N Engl J Med 361 26 2009 2538 2547
19. J.T. Saunders, V. Nambi, J.A. de Lemos Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study Circulation 123 13 2011 1367 1376
20. T. Tsutamoto, C. Kawahara, M. Yamaji Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure Eur J Heart Fail 11 7 2009 653 658
21. M.L. Ford, E.R. Smith, L.A. Tomlinson, P.K. Chatterjee, C. Rajkumar, S.G. Holt FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4 Another link between chronic kidney disease-mineral bone disorder and the heart Nephrol Dial Transplant 27 2 2012 727 733
22. A.Y. Wang, K.N. Lai Use of cardiac biomarkers in end-stage renal disease J Am Soc Nephrol 19 9 2008 1643 1652
23. A.S. Levey, T. Greene, J.W. Kusek, G.L. Beck MDRD Study Group A simplified equation to predict glomerular filtration rate from serum creatinine (abstract) J Am Soc Nephrol 11 2000 155A
24. L.A. Stevens, J. Coresh, C.H. Schmid Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD Am J Kidney Dis 51 3 2008 395 406 (Pubitemid 351273480)
25. E. Giannitsis, K. Kurz, K. Hallermayer, J. Jarausch, A.S. Jaffe, H.A. Katus Analytical validation of a high-sensitivity cardiac troponin T assay Clin Chem 56 2 2010 254 261
26. N. Kumar, M.F. Michelis, M.V. DeVita, G. Panagopoulos, J.L. Rosenstock Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay Nephrol Dial Transplant 26 2 2011 665 670
27. B. Conway, M. McLaughlin, P. Sharpe, J. Harty Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis Nephrol Dial Transplant 20 12 2005 2759 2764 (Pubitemid 41672277)
28. T. Isakova, H. Xie, A. Barchi-Chung Fibroblast growth factor 23 in patients undergoing peritoneal dialysis Clin J Am Soc Nephrol 6 11 2011 2688 2695
29. A.S. Agatston, W.R. Janowitz, F.J. Hildner, N.R. Zusmer, M. Viamonte Jr, R. Detrano Quantification of coronary artery calcium using ultrafast computed tomography J Am Coll Cardiol 15 4 1990 827 832 (Pubitemid 20101575)
30. M.A. Mirza, A. Larsson, L. Lind, T.E. Larsson Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community Atherosclerosis 205 2 2009 385 390
31. D.S. Ooi, D. Zimmerman, J. Graham, G.A. Wells Cardiac troponin T predicts long-term outcomes in hemodialysis patients Clin Chem 47 3 2001 412 417 (Pubitemid 32222453)
32. J. Dierkes, U. Domrose, S. Westphal Cardiac troponin T predicts mortality in patients with end-stage renal disease Circulation 102 16 2000 1964 1969
33. N.A. Khan, B.R. Hemmelgarn, M. Tonelli, C.R. Thompson, A. Levin Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis Circulation 112 20 2005 3088 3096 (Pubitemid 43113440)
34. N.A. Abbas, R.I. John, M.C. Webb Cardiac troponins and renal function in nondialysis patients with chronic kidney disease Clin Chem 51 11 2005 2059 2066 (Pubitemid 41532621)
35. A.Y. Wang, C.W. Lam, M. Wang Prognostic value of cardiac troponin T is independent of inflammation, residual renal function, and cardiac hypertrophy and dysfunction in peritoneal dialysis patients Clin Chem 53 5 2007 882 889 (Pubitemid 46744244)
36. C. deFilippi, S. Wasserman, S. Rosanio Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis JAMA 290 3 2003 353 359 (Pubitemid 37430521)
37. F.S. Apple, M.M. Murakami, L.A. Pearce, C.A. Herzog Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease Circulation 106 23 2002 2941 2945 (Pubitemid 35424746)
38. F. Mallamaci, C. Zoccali, S. Parlongo Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients Am J Kidney Dis 40 1 2002 68 75 (Pubitemid 34701213)
39. M. Goicoechea, S. Garca de Vinuesa, F. Gomez-Campdera Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk Am J Kidney Dis 43 5 2004 846 853 (Pubitemid 38529622)
40. D.S. Ooi, P.A. Isotalo, J.P. Veinot Correlation of antemortem serum creatine kinase, creatine kinase-MB, troponin I, and troponin T with cardiac pathology Clin Chem 46 3 2000 338 344 (Pubitemid 30152259)
41. E.M. Antman, C. Grudzien, R.N. Mitchell, D.B. Sacks Detection of unsuspected myocardial necrosis by rapid bedside assay for cardiac troponin T Am Heart J 133 5 1997 596 598 (Pubitemid 27208939)
42. M.C. Iliou, C. Fumeron, M.O. Benoit Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis and New Cardiac Markers Evaluation (CHANCE) Study Nephrol Dial Transplant 16 7 2001 1452 1458 (Pubitemid 32640603)
43. D. Duman, S. Tokay, A. Toprak, A. Oktay, I.C. Ozener, O. Unay Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients Nephrol Dial Transplant 20 5 2005 962 967 (Pubitemid 40704034)
44. J.J. McMurray, H. Uno, P. Jarolim Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce Cardiovascular Events With Aranesp (darbepoetin-alfa) Therapy (TREAT) Am Heart J 162 4 2011 748 755 e743
45. K. Negishi, M. Kobayashi, I. Ochiai Association between fibroblast growth factor 23 and left ventricular hypertrophy in maintenance hemodialysis patients Comparison with B-type natriuretic peptide and cardiac troponin T Circ J 74 12 2010 2734 2740
46. R.M. Holden, D. Beseau, S.L. Booth FGF-23 is associated with cardiac troponin T and mortality in hemodialysis patients Hemodial Int 16 1 2012 53 58
47. S.J. Hur, D.M. Kim, K.H. Lim Vitamin D levels and their relationship with cardiac biomarkers in chronic hemodialysis patients J Korean Med Sci 24 suppl 1 2009 S109 S114
48. S.A. Burnett-Bowie, B.Z. Leder, M.P. Henao, C.M. Baldwin, D.L. Hayden, J.S. Finkelstein Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23 Clin J Am Soc Nephrol 7 4 2012 624 631
49. T.J. Wang, M.J. Pencina, S.L. Booth Vitamin D deficiency and risk of cardiovascular disease Circulation 117 4 2008 503 511